参考文献
(在框内滑动手指即可浏览)
[1] Fagin JA,Wells SJ. Biologic and Clinical Perspectives on Thyroid Cancer[J]. N Engl J Med,2016,375(11):1054-1067.
[2] Bible KC,Kebebew E,Brierley J,et al. 2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer[J]. Thyroid,2021,31(3):337-386.
[3] Song E,Song DE,Ahn J,et al. Genetic profile of advanced thyroid cancers in relation to distant metastasis[J]. Endocr Relat Cancer,2020,27(5):285-293.
[4] Yoo SK,Song YS,Lee EK,et al. Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer[J]. Nat Commun,2019,10(1):2764.
[5] Xu B,Fuchs T,Dogan S,et al. Dissecting anaplastic thyroid carcinoma: A comprehensive clinical,histologic, immunophenotypic,and molecular study of 360 cases[J]. Thyroid,2020,30(10):1505-1517.
[6] Chintakuntlawar AV,Yin J,Foote RL,et al. A phase 2 study of pembrolizumab combined with chemoradiotherapy as initial treatment for anaplastic thyroid cancer[J]. Thyroid,2019,29(11):1615-1622.
[7] Foote RL,Molina JR,Kasperbauer JL,et al. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma:A single-institution experience using aggressive multimodal therapy[J]. Thyroid,2011,21(1):25-30.
[8] Lee N,Xia P,Quivey JM,et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience[J]. Int J Radiat Oncol Biol Phys,2002,53(1):12-22.
[9] Bhide SA,Kazi R,Newbold K,et al. The role of intensity-modulated radiotherapy in head and neck cancer[J]. Indian J Cancer,2010,47(3):267-273.
[10] 杨伟伟,只璟泰,郑向前.局部转移性晚期甲状腺癌分子靶向药物治疗[J]. 中国实用外科杂志,2019,39(3):209-212.
[11] Maniakas A,Dadu R,Busaidy NL,et al. Evaluation of overall survival in patients with anaplastic thyroid carcinoma,2000-2019[J]. JAMA Oncol,2020,6(9):1397-1404.
[12] Rao SN,Zafereo M,Dadu R,et al. Patterns of treatment failure in anaplastic thyroid carcinoma[J]. Thyroid,2017,27(5):672-681.
[13] Iyer PC,Dadu R,Gule-Monroe M,et al. Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma[J]. J Immunother Cancer,2018,6(1):68.
[14] Ryken TC,Mcdermott M,Robinson PD,et al. The role of steroids in the management of brain metastases: A systematic review and evidence-based clinical practice guideline[J]. J Neurooncol,2010,96(1):103-114.
[15] Forsyth PA,Weaver S,Fulton D,et al. Prophylactic anticonvulsants in patients with brain tumour[J]. Can J Neurol Sci,2003,30(2):106-112.